SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* SACKS RODNEY C (Last) (First) (Middle) 1 MONSTER WAY (Street) CORONA CA 92879 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol Monster Beverage Corp [ MNST ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner X Officer (give title below) Other (specify below) Chairman and Co-CEO
	3. Date of Earliest Transaction (Month/Day/Year) 02/02/2022
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$59.67							(1)	03/14/2029	Common Stock	97,200		97,200	I	By Hilrod Holdings XXVI, L.P.(2)
Employee Stock Option (right to buy)	$62.39							(3)	03/13/2030	Common Stock	(4)		106,334	D
Employee Stock Option (right to buy)	$62.39							(1)	03/13/2030	Common Stock	(4)		85,066	I	By Hilrod Holdings XXIII, L.P.(2)
Employee Stock Option (right to buy)	$88.94							(5)	03/12/2031	Common Stock	(4)		129,900	D
Employee Stock Option (right to buy)	$73.23	03/14/2022		A		145,700		(6)	03/14/2032	Common Stock	145,700	$0	145,700	D
Restricted Stock Units	(7)	03/14/2022		M			33,534	(8)	(9)	Common Stock	33,534	$0	0	D
Restricted Stock Units	(7)	03/14/2022		M			16,028	(10)	(9)	Common Stock	16,028	$0	16,028	D
Restricted Stock Units	(11)	03/14/2022		M			12,633	(12)	(9)	Common Stock	12,633	$0	25,267	D
Restricted Stock Units	(11)	03/14/2022		A		46,100		(13)	(9)	Common Stock	46,100	$0	46,100	D

Explanation of Responses:

1. The options are currently vested.

2. Reporting person (i) is one of the general partners of each of Brandon Limited Partnership No. 1, Brandon Limited Partnership No. 2, Hilrod Holdings IV, L.P., Hilrod Holdings V, L.P., Hilrod Holdings VI, L.P., Hilrod Holdings VII, L.P., Hilrod Holdings VIII, L.P., Hilrod Holdings IX, L.P., Hilrod Holdings X, L.P., Hilrod Holdings XI, L.P., Hilrod Holdings XII, L.P., Hilrod Holdings XIII, L.P., Hilrod Holdings XIV, L.P., Hilrod Holdings XV, L.P., Hilrod Holdings XVI, L.P., Hilrod Holdings XVII, L.P., Hilrod Holdings XVIII, L.P., Hilrod Holdings XIX, L.P., Hilrod Holdings XX, L.P., Hilrod Holdings XXI, L.P., Hilrod Holdings XXII, L.P., Hilrod Holdings XXIII, L.P., Hilrod Holdings XXIV, L.P., Hilrod Holdings XXV, L.P. and Hilrod Holdings XXVI, L.P., (ii) is the trustee of HHS 2010 GRAT #3 and HHS 2014 GRAT #2 and (iii) disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

3. The options are currently vested with respect to 53,167 shares. The remaining options vest on March 13, 2023.

4. No transaction is being reported at this time. This line is only reporting holdings as of the date hereof.

5. The options are currently vested with respect to 43,300 shares. The remaining options vest in two equal installments on March 12, 2023 and March 12, 2024.

6. The options vest in three installments as follows: 48,566 shares on March 14, 2023; 48,567 shares on March 14, 2024 and 48,567 shares on March 14, 2025.

7. The restricted stock units were granted under the 2011 Omnibus Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock as of the vesting date.

8. The restricted stock units are fully vested.

9. Not applicable.

10. The remaining restricted stock units vest on March 13, 2023.

11. The restricted stock units were granted under the 2020 Omnibus Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock as of the vesting date.

12. The remaining restricted stock units vest in two installments as follows: 12,633 units on March 12, 2023 and 12,634 units on March 12, 2024.

13. The restricted stock units vest in three installments as follows: 15,366 units on March 14, 2023; 15,367 units on March 14, 2024 and 15,367 units on March 14, 2025.

Remarks:

Due to limitations on number of entries per table, this Form 4 consists of two parts filed concurrently. Part I and Part II of the Reporting Person's Form 4 shall constitute one filing. This is Part II of II.

	Paul J. Dechary, attorney-in-fact	03/16/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.